Proteomics

Dataset Information

0

Mouse liver kidney LC-MS/MS - Quantitative Proteomics and Targeted Fatty Acids Analysis Reveal the Damage of Triptolide in Liver and Kidney


ABSTRACT: Triptolide (TP), the major active component in Tripterygium wilfordii Hook. f. (Tripterygium Glycosides), contributes to treat rheumatoid arthritis and anticancer activities. However, the organ toxicity, especially nephrotoxicity and hepatotoxicity limit its clinical application. To fully understand the mechanism underlying the triptolide induced toxicity, iTRAQ based proteomics and targeted fatty acids analysis were performed. In the present study, mouse were treated with LD50 dose of triptolide, and plasma, liver and kidney tissues were harvested before drug administration (0 h) and after drug administration (0.5 h, 1 h, 2 h, 8 h, 16 h). The blood biochemical levels (ALT, AST, BUN and CRE) were used to evaluated the toxicity of triptolide. 2D-LC-MS/MS approach was used to compare different proteins among groups 0h, 1h, 2h and 8 h. Functional annotation of different proteins in liver between different groups reveals that the top 3 pathways influenced by the TP were acute phase response signaling, antigen presentation pathway and FXR/RXR activation, the molecular and cellular functions which was mainly effected were lipid metabolism and small molecule biochemistry. In kidney, the pathway including LPS/IL-1 Mediated Inhibition of RXR Function, EIF2 Signaling, acute phase response signaling, and LXR/RXR Activation were mainly affected. The proteomics data implicated that fatty acids (FAs) may involve in the organ toxicity induced by TP. Then targeted fatty acids analysis was carried out to determinate the concentration between the different groups (0.5 h, 1 h, 2 h, 8 h, 16 h) by HPLC-MRM. We found that fatty acids in liver (C17:0, C18:0, C18:2, C18:3, C20:0, C20:3, C20:4, C22:1, C22:2, C22:3, C22:4, C22:5, C22:6, C24:0, C24:1, C24:2, C24:3, C24:4, C24:5, C24:6) show significant difference among groups, while in kidney, FAs (C12:0, C12:1, C14:0, C14:1, C16:1, C16:2) show significant difference. P450 protein family show significant change in different group, protein CYP4A14 demonstrate change in both kidney and liver tissues. By combing proteomics and targeted FAs analysis, we deeply investigated the mechanism underlying the TP induced organ toxicity, and the results may provide deeply insight into prevention or intervention in the TP clinical usage and improving its safety.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Liver, Kidney

SUBMITTER: Menglin Li  

LAB HEAD: Jinlan Zhang

PROVIDER: PXD005434 | Pride | 2018-07-05

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
F001590.mzid.gz Mzid
F001590.pride.mztab.gz Mztab
F001591.mzid.gz Mzid
F001591.pride.mztab.gz Mztab
F001592.mzid.gz Mzid
Items per page:
1 - 5 of 600
altmetric image

Publications

Quantitative Proteomics and Targeted Fatty Acids Analysis Reveal the Damage of Triptolide in Liver and Kidney.

Li Menglin M   Hu Ting T   Tie Cai C   Qu Liang L   Zheng Hao H   Zhang Jinlan J  

Proteomics 20171025 22


Triptolide (TP), the major active component in Tripterygium wilfordii Hook. f., is widely used for the treatment of rheumatoid arthritis and autoimmune diseases. However, organ toxicity, especially hepatotoxicity and nephrotoxicity, limits its clinical application. To fully understand the mechanism underlying TP toxicity, iTRAQ-based 2D-LC-MS/MS proteomics is used to detect differentially expressed proteins in the livers and kidneys of mice administered the LD50 dose of TP. Functional annotation  ...[more]

Similar Datasets

2022-05-06 | GSE202175 | GEO
2008-06-16 | E-GEOD-8396 | biostudies-arrayexpress
2016-03-18 | GSE77104 | GEO
2021-12-14 | PXD025935 | Pride
2023-10-19 | GSE213782 | GEO
2019-09-20 | GSE123494 | GEO
2010-10-09 | GSE20944 | GEO
2011-11-30 | E-GEOD-34045 | biostudies-arrayexpress
2010-08-12 | E-GEOD-17666 | biostudies-arrayexpress
2011-11-30 | GSE34045 | GEO